000 01267 a2200349 4500
005 20250515230121.0
264 0 _c20101124
008 201011s 0 0 eng d
022 _a1744-7623
024 7 _a10.1517/14728214.2010.497754
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFung, Christopher
245 0 0 _aEmerging drugs to treat squamous cell carcinomas of the head and neck.
_h[electronic resource]
260 _bExpert opinion on emerging drugs
_cSep 2010
300 _a355-73 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aCetuximab
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Design
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPrecision Medicine
_xmethods
700 1 _aGrandis, Jennifer R
773 0 _tExpert opinion on emerging drugs
_gvol. 15
_gno. 3
_gp. 355-73
856 4 0 _uhttps://doi.org/10.1517/14728214.2010.497754
_zAvailable from publisher's website
999 _c19906288
_d19906288